Literature DB >> 21643942

Progression of coronary artery calcium in men affected by human immunodeficiency virus infection.

Giovanni Guaraldi1, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Federica Fiocchi, Rosario Rossi, Maria Grazia Modena, Paolo Raggi.   

Abstract

Cardiovascular risk is increased in HIV infected patients. We assessed progression of coronary artery calcium (CAC) in patients with HIV infection to identify factors that may help explain progression of atherosclerosis. Prospective, observational study of 132 HIV-infected men receiving chronic antiretroviral therapy (ART); we measured traditional atherosclerosis risk factors and assessed progression of CAC on sequential 64-slice CT scans at an average interval of 11 months (range 6-36). CAC score progression was defined as absolute and percentage change from baseline. During follow-up 45 patients (34%) showed absolute progression of CAC and 34 of them showed >15% yearly progression, a threshold previously associated with a high risk of myocardial infarction. Age, LDL cholesterol, visceral abdominal fat and current T-helper (CD4+) cell count were significantly associated with absolute CAC progression. Progression of subclinical atherosclerosis in HIV patients is associated with traditional coronary risk factors as well as HIV related factors such as the CD4+ cell count. Therefore, immunologic perturbations secondary to HIV infection may contribute to atherosclerosis progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643942     DOI: 10.1007/s10554-011-9898-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  20 in total

1.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

2.  Coronary aging in HIV-infected patients.

Authors:  Giovanni Guaraldi; Stefano Zona; Nikolaos Alexopoulos; Gabriella Orlando; Federica Carli; Guido Ligabue; Federica Fiocchi; Antonella Lattanzi; Rosario Rossi; Maria Grazia Modena; Roberto Esposito; Frank Palella; Paolo Raggi
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

3.  Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Authors:  Janet Lo; Suhny Abbara; Leon Shturman; Anand Soni; Jeffrey Wei; Jose A Rocha-Filho; Khurram Nasir; Steven K Grinspoon
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects.

Authors:  Giovanni Guaraldi; Chiara Stentarelli; Stefano Zona; Gabriella Orlando; Federica Carli; Guido Ligabue; Antonella Lattanzi; Giacomo Zaccherini; Rosario Rossi; Maria Grazia Modena; Nikolaos Alexopoulos; Frank Palella; Paolo Raggi
Journal:  Atherosclerosis       Date:  2009-06-18       Impact factor: 5.162

5.  Progression of coronary artery calcium in type 1 diabetes mellitus.

Authors:  Tina Costacou; Daniel Edmundowicz; Catherine Prince; Baqiyyah Conway; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2007-09-27       Impact factor: 2.778

6.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients.

Authors:  Matthew J Budoff; Leslee J Shaw; Sandy T Liu; Steven R Weinstein; Tristen P Mosler; Philip H Tseng; Ferdinand R Flores; Tracy Q Callister; Paolo Raggi; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2007-04-20       Impact factor: 24.094

7.  Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy.

Authors:  Paolo Raggi; Tracy Q Callister; Leslee J Shaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-01       Impact factor: 8.311

8.  Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients.

Authors:  A Tabib; C Leroux; J F Mornex; R Loire
Journal:  Coron Artery Dis       Date:  2000-02       Impact factor: 1.439

9.  Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.

Authors:  Niels Obel; Henrik F Thomsen; Gitte Kronborg; Carsten S Larsen; Per R Hildebrandt; Henrik T Sørensen; Jan Gerstoft
Journal:  Clin Infect Dis       Date:  2007-05-10       Impact factor: 9.079

10.  T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.

Authors:  Robert C Kaplan; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Peter Hunt; Roksana Karim; David M Kern; Howard N Hodis; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

View more
  20 in total

1.  Coronary risk assessment in patients with HIV infection: why bother?

Authors:  Stefan Möhlenkamp; Nico Reinsch; Raimund Erbel; Till Neumann
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-26       Impact factor: 2.357

2.  HIV and coronary artery calcium score: comparison of the Hawaii Aging with HIV Cardiovascular Study and Multi-Ethnic Study of Atherosclerosis (MESA) cohorts.

Authors:  Dominic Chow; Rebekah Young; Nicole Valcour; Richard A Kronmal; Corey J Lum; Nisha I Parikh; Russell P Tracy; Matthew Budoff; Cecilia M Shikuma
Journal:  HIV Clin Trials       Date:  2015-06-03

3.  Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.

Authors:  Priya Bhagwat; Ighovwerha Ofotokun; Grace A McComsey; Todd T Brown; Carlee Moser; Catherine A Sugar; Judith S Currier
Journal:  Antivir Ther       Date:  2017-03-01

4.  Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals.

Authors:  David C Lange; David Glidden; Eric A Secemsky; Karen Ordovas; Steven G Deeks; Jeffrey N Martin; Ann F Bolger; Priscilla Y Hsue
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

5.  Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Authors:  Takara L Stanley; Julian Falutz; Christian Marsolais; Josée Morin; Graziella Soulban; Jean-Claude Mamputu; Hani Assaad; Ralph Turner; Steven K Grinspoon
Journal:  Clin Infect Dis       Date:  2012-04-10       Impact factor: 9.079

Review 6.  Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.

Authors:  Ovidiu Galescu; Amrit Bhangoo; Svetlana Ten
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

7.  Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS).

Authors:  Sai Krishna C Korada; Di Zhao; Martin Tibuakuu; Todd T Brown; Lisa P Jacobson; Eliseo Guallar; Robert K Bolan; Frank J Palella; Joseph B Margolick; Jeremy J Martinson; Matthew J Budoff; Wendy S Post; Erin D Michos
Journal:  Atherosclerosis       Date:  2017-08-26       Impact factor: 5.162

8.  The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study.

Authors:  Honor Rose; Hann Low; Elizabeth Dewar; Michael Bukrinsky; Jennifer Hoy; Anthony Dart; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2013-04-17       Impact factor: 5.162

9.  Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study).

Authors:  Michael I Brener; Wendy S Post; Sabina A Haberlen; Long Zhang; Frank J Palella; Lisa P Jacobson; Adrian S Dobs; Richard T George; Mallory D Witt; Matthew Budoff; Lawrence A Kingsley; Todd T Brown
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

10.  Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.

Authors:  Gretchen E Volpe; Alice M Tang; Joseph F Polak; Alexandra Mangili; Sally C Skinner; Christine A Wanke
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.